TRCT
KMTS

Tower Research Capital (TRC)’s Kestra Medical Technologies KMTS Stock Holding History

Tower Research Capital (TRC)’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$45.2K Buy
2,270
+1,534
+208% +$36.2K ﹤0.01% 2827
2025
Q4 		$19.5K Buy
736
+38
+5% +$979 ﹤0.01% 3111
2025
Q3 		$16.6K Buy
698
+596
+584% +$10.7K ﹤0.01% 3469
2025
Q2 		$1.69K Buy
+102
New +$2.23K ﹤0.01% 4761

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AP
Andera Partners Paris $177M AUM
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Tower Research Capital (TRC)'s KMTS Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its Kestra Medical Technologies (KMTS) stake by 208% in Q1 2026, buying an estimated $36.2K and bringing the position to 2,270 shares worth $45.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2827.

Tower Research Capital (TRC) first reported a position in KMTS in Q2 2025 and has held it in 4 quarters since. 103 funds tracked by Wall St. Rank hold KMTS as of Q1 2026.

  • Tower Research Capital (TRC) held 2,270 shares of Kestra Medical Technologies worth $45.2K as of Q1 2026.
  • Tower Research Capital (TRC) bought 1,534 Kestra Medical Technologies shares in Q1 2026, an estimated $36.2K.
  • Kestra Medical Technologies made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #2827 holding.
  • Tower Research Capital (TRC) first reported a position in Kestra Medical Technologies in Q2 2025 and has held it in 4 quarters since.
  • 103 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.